Study for people with Type 2 Diabetes

Recruiting Not a phased study

Sources: ClinicalTrials.gov Checked: 11 October 2026 Not medical advice

This trial at a glance

Status Recruiting
Phase Not a phased study
Sponsor University of Cambridge
Registry number NCT06579404
Started 6 December 2024 Today 16 October 2026 Estimated completion 1 March 2027

Where this trial is running

Trial sites and the status recorded for each
SiteCityState or countryStatus at this site
University of Melbourne Melbourne Australia Not yet recruiting

voxsanity.com.au · trial sites from public registries · registry record synced 11 October 2026 · not medical advice

Who can join

Age 18 Years and over
Sex Anyone, regardless of sex
Healthy volunteers Not accepted
Enrolment target 224

The official eligibility criteria

Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.

Inclusion Criteria:

* Aged 18 years and older

* Type 2 diabetes diagnosed for at least 12 months

* Established on an SGLT2 inhibitor and/or GLP-1 receptor agonist for at least 3 months, or have been offered these therapies previously.

* Treatment with insulin therapy for at least 6 months

* HbA1c ≤ 15% (140 mmol/mol) analysis from local laboratory or equivalent

* Willing to wear study devices and follow study instructions

* Capacity to consent to participate in the study

Exclusion Criteria:

* Type 1 diabetes

* Current use of insulin pump

* Current use of any closed-loop system

* Any physical/psychological disease or medication(s) likely to interfere with the conduct of the study and interpretation of the study results, as judged by study clinician

* Known or suspected allergy against insulin

* Medically documented allergy towards the adhesive

* Pregnancy, planned pregnancy, or breast feeding

* Severe visual impairment

* Severe hearing impairment

* Medically documented allergy towards the adhesive (glue) of plasters

* Serious skin diseases located at places of the body, which potentially are possible to be used for localisation of the glucose sensor

* Illicit drugs abuse

* Prescription drugs abuse

* Alcohol abuse

Dates on the record

Started 6 December 2024
Estimated completion 1 March 2027
Registry last updated 13 March 2026
Checked by Voxsanity 11 October 2026

Results, publications and the official record

Sources and dates

  • ClinicalTrials.gov – the record this page reformats
  • ClinicalTrials.gov processing date: 13 March 2026.
  • This page last checked by Voxsanity: 11 October 2026.

Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.

Not medical advice.

Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.

Letter for your doctor

A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.